BELLUS Health Inc. (BLU)

BLU was delisted on the 28th of June, 2023.

• Market cap: $1.87B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Employees: 74